No megamergers, but healthcare deals up in Q2: PwC
There were about 281 health services deals in the second quarter, which is down 7.3% compared to the same quarter last year but up compared to the first quarter of this year, according to a new report from PwC. (Getty/peterspiro)
The overall number of deals in the healthcare sector rose more than 7% in the second quarter compared to earlier this year, according to a new report from PwC.
However, there were no megadeals, and total deal volume in the second quarter was $15 billion, down about 40% compared to the same quarter of 2018 and down about 51% compared to the first quarter.
There were about 281 deals, which is down 7.3% compared to the same quarter last year. It is the eighth quarter in a row with more than 250 deals.
Free Daily Newsletter
Like this story? Subscribe to FierceHealthcare!
The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.
Key drivers of deal activity include tax reform impact, inpatient volume pressure, cross-industry deals and vertical integration and the evolution of technology.